MiMedx Group Investor Relations Material
Latest events
Q1 2025
MiMedx Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from MiMedx Group Inc
Access all reports
MiMedx Group Inc. is a biopharmaceutical company specializing in regenerative medicine. The company develops and markets advanced products derived from human placental tissue to support wound healing and tissue repair. MiMedx’s solutions are used in areas such as chronic wound care, surgical applications, and musculoskeletal conditions. The company is headquartered in Marietta, Georgia, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
MDXG
Country
🇺🇸 United States